J9358 Fam-trastuzumab deruxtecan-nxki - CanMED: HCPCS

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Fam-trastuzumab deruxtecan-nxki

Brand Name:

Enhertu

Strength:

1mg

HCPCS:

J9358

SEER*Rx Category:

Immunotherapy

Major Drug Class:

Drug Antibody Conjugate

Minor Drug Class:

HER2, topoisomerase, tetrapeptide

Oral (Y/N):

No

FDA Approval Year:

2019

FDA Discontinuation Year:

CMS Effective Date:

July 1, 2020

CMS Discontinuation Date:

Status:

In Use